MDMA-assisted therapy for war-related PTSD
Part of Mental health clinical trials.
This study tests whether combining MDMA with talk therapy can help people with post-traumatic stress disorder (PTSD) from war experiences. It involves both individual and group therapy sessions, and the medication is given during some sessions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have experienced trauma related to war.
- You speak and read Hebrew fluently.
- You are able to swallow capsules.
- You are willing to have study visits recorded (audio and/or video).
- You can identify a support person (like a relative or close friend) who can be contacted if needed.
- You are willing to follow study rules, like fasting before sessions and staying overnight after each medication session.
- You have a current PTSD diagnosis and moderate to severe symptoms at screening.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether MDMA (the drug in ecstasy) combined with a type of talk therapy called massed exposure therapy can help treat PTSD. It may be an option if standard treatments haven't worked well enough.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
This study tests whether MDMA (a drug that can help people feel safe and open during therapy) combined with talk therapy can reduce PTSD symptoms in active-duty service members, National Guard, and Reserve members. If you are struggling with PTSD that has lasted at least 6 months, this trial may offer a new treatment option.
This study tests whether MDMA, combined with a type of talk therapy called CBCT (cognitive behavioral conjoint therapy), is more effective than CBCT alone for treating PTSD. You and a close partner will both participate in therapy sessions and take MDMA together.
This Phase 2 trial tests whether therapy assisted by MDMA can reduce symptoms of moderate to severe post-traumatic stress disorder (PTSD) in eligible veterans. It includes supervised therapy sessions and extra study visits with video recording to track changes over time.
This study tests whether MDMA-assisted therapy can help veterans who have both PTSD and alcohol use disorder. If you have tried a standard therapy before and want to reduce or stop drinking, this treatment may offer a new option.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.